H. Tsimiklis

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
H Tsimiklis, H. Tsimiklis, Helen Tsimiklis
Publication record
58 papers · 6,787 citations · H-index 27

PAPERS

Fecal Sample Collection for Gut Microbiome Research in a Prospective Cohort: A Pilot Study within the Australian Breakthrough Cancer Study
20250 citationsauthor #5
Anti‐Parietal Cell Antibodies Show Differential Associations With Stomach Cancer by Site and Helicobacter pylori Status
20250 citationsauthor #5
Smart non-uniformity: Calibration of sequencing depth of a targeted gene panel to simultaneously detect somatic and germline variants.
20250 citationsauthor #9
Saliva-derived DNA is suitable for the detection of clonal haematopoiesis of indeterminate potential
20244 citationsauthor #8
1322A pilot study of faecal sample collection from prospective cohort study participants
20210 citationsauthor #5
Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer
202117 citationsauthor #11
VTRNA2-1: Genetic Variation, Heritable Methylation and Disease Association
202120 citationsauthor #6
Population-based estimates of breast cancer risk for carriers of pathogenic variants identified by gene-panel testing
20210 citationsauthor #18
Population-Based Estimates of the Age-Specific Cumulative Risk of Breast Cancer for Pathogenic Variants in CHEK2: Findings from the Australian Breast Cancer Family Registry
20219 citationsauthor #9
Abstract PS7-04: Population-based estimates of breast cancer risk for germline pathogenic variants identified by gene-panel testing: An Australian perspective
20210 citationsauthor #15
Population-based estimates of breast cancer risk for carriers of pathogenic variants identified by gene-panel testing
202117 citationsauthor #18
Genetic testing in Poland and Ukraine: should comprehensive germline testing of BRCA1 and BRCA2 be recommended for women with breast and ovarian cancer?
202017 citationsauthor #8
Exposure to household air pollution over 10 years is related to asthma and lung function decline
202024 citationsauthor #10
Rare germline genetic variants and risk of aggressive prostate cancer
202017 citationsauthor #5
Human Milk Oligosaccharide profiles and allergic disease up to 18 years.
202040 citationsauthor #6
Mismatch repair gene pathogenic germline variants in a population-based cohort of breast cancer
20209 citationsauthor #8
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (vol 5, 4999, 2014)
20181 citationsauthor #110
FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine
201822 citationsauthor #7
Novel associations between blood DNA methylation and body mass index in middle-aged and older adults
201865 citationsauthor #16
Is RNASEL:p.Glu265* a modifier of early-onset breast cancer risk for carriers of high-risk mutations?
20189 citationsauthor #6
Targeted massively parallel sequencing characterises the mutation spectrum of PALB2 in breast and ovarian cancer cases from Poland and Ukraine
201710 citationsauthor #7
Body mass index and breast cancer survival: a Mendelian randomization analysis
201755 citationsauthor #128
Mould‐sensitized adults have lower Th2 cytokines and a higher prevalence of asthma than those sensitized to other aeroallergens
20167 citationsauthor #10
PALB2,CHEK2 and ATM rare variants and cancer risk: Data from COGS
2016173 citationsauthor #21
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
2016110 citationsauthor #219
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
201620 citationsauthor #317
Identiﬁcation of four novel susceptibility loci for oestrogen receptor negative breast cancer
20164 citationsauthor #181
Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry
201530 citationsauthor #4
Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
201591 citationsauthor #16
Hi-Plex targeted sequencing is effective using DNA derived from archival dried blood spots.
20156 citationsauthor #5
Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer.
201516 citationsauthor #80
Common germline polymorphisms associated with breast cancer-specific survival
201533 citationsauthor #49
Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry
201597 citationsauthor #8
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
2015577 citationsauthor #133
Identification of Novel Genetic Markers of Breast Cancer Survival
2015195 citationsauthor #49
Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
2015547 citationsauthor #123
Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization.
2015122 citationsauthor #84
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
2014120 citationsauthor #110
Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers.
201452 citationsauthor #8
Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer
2014100 citationsauthor #7
MicroRNA Related Polymorphisms and Breast Cancer Risk
2014560 citationsauthor #28
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
20131,124 citationsauthor #117
Hi-Plex for high-throughput mutation screening: application to the breast cancer susceptibility gene PALB2
20131 citationsauthor #6
Hi-Plex for high-throughput mutation screening: application to the breast cancer susceptibility gene PALB2
201316 citationsauthor #6
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
2013120 citationsauthor #13
The use of DNA from archival dried blood spots with the Infinium HumanMethylation450 array
201368 citationsauthor #5
Cross-platform compatibility of Hi-Plex, a streamlined approach for targeted massively parallel sequencing.
201312 citationsauthor #5
Genome-wide association studies identify four ER negative–specific breast cancer risk loci
2013435 citationsauthor #198
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
2013561 citationsauthor #219
Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model
201344 citationsauthor #6
Genome-wide association analysis identifies three new breast cancer susceptibility loci
2012304 citationsauthor #38
Identification of new breast cancer predisposition genes via whole exome sequencing
20120 citationsauthor #17
Expanded genetic analysis of a PALB2 c.3113G>A mutation carrying multiple-case breast cancer family via exome sequencing
20120 citationsauthor #6
Rare mutations in XRCC2 increase the risk of breast cancer.
2012183 citationsauthor #17
Identification of new breast cancer predisposition genes via whole exome sequencing
20121 citationsauthor #17
Expanded genetic analysis of a PALB2 c.3113G>A mutation carrying multiple-case breast cancer family via exome sequencing
20120 citationsauthor #6
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.
2011696 citationsauthor #167
Rare Mutations in XRCC 2 Increase the Risk of Breast Cancer
year unknown28 citationsauthor #16

TIMELINE

2011 696 citations

2012 488 citations

2013 2,381 citations

2014 832 citations

2015 1,714 citations

2016 314 citations

2017 65 citations

2018 97 citations

2020 107 citations

2021 63 citations

2024 4 citations

2025 0 citations

Unknown 28 citations

COAUTHOR MAP

CONCEPT FOOTPRINT